8 March 2018 EMA/154207/2018 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: ketorolac (ophtalmic formulations)

Procedure no.: PSUSA/00001810/201707

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

ACULAR 0,5 POUR CENT,

not available

NL 16248

ALLERGAN FRANCE

FR

IE/H/0101/001

1-21783

ALLERGAN

AT

collyre ACULAR 0,5% Augentropfen ACULAR 0,5% p/v collirio,

PHARMACEUTICALS IRELAND IE/H/0101/001

033222023

ALLERGAN S.P.A.

IT

IE/H/0101/001

033222035

ALLERGAN S.P.A.

IT

IE/H/0101/001

PA 148/57/1

ALLERGAN

IE

soluzione ACULAR 0,5% p/v collirio, soluzione ACULAR 0.5% w/v Eye drops, solution Acular 0.5% w/v,

PHARMACEUTICALS IRELAND not available

89597/12-12-2013

οφθαλμικές σταγόνες,

ALLERGAN

GR

PHARMACEUTICALS IRELAND

διάλυμα Acular 0.5%,

not available

RVG 13381

oogdruppels, oplossing ACULAR 5 mg/ml

NL

PHARMACEUTICALS IRELAND not available

16217.00.00

Augentropfen ACULAR 5 mg/ml Colirio

ALLERGAN

ALLERGAN

DE

PHARMACEUTICALS IRELAND IE/H/0101/001

61.690

ALLERGAN, S.A.U.

ES

IE/H/0101/001

2538288

ALLERGAN, S.A.U.

PT

en solución ACULAR 5 mg/ml Colírio, solução

List of nationally authorised medicinal products EMA/154207/2018

Page 2/4

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

ACULAR 5 mg/ml Colírio,

IE/H/0101/001

2538387

ALLERGAN, S.A.U.

PT

IE/H/0101/001

2538486

ALLERGAN, S.A.U.

PT

not available

11774

ALLERGAN

FI

solução ACULAR 5 mg/ml Colírio, solução Acular 5 mg/ml, silmätipat, liuos ACULAR, 5 mg/ml, krople

PHARMACEUTICALS IRELAND not available

11327

do oczu, roztwór Acular, øjendråber,

ALLERGAN

PL

PHARMACEUTICALS IRELAND not available

15754

opløsning

ALLERGAN

DK

PHARMACEUTICALS IRELAND

Acular®

not available

PL 00426/0082

ALLERGAN LTD

UK

ACULAR® 5 mg/ml

not available

11774

ALLERGAN

FI

ögondroppar, lösning ACULARE 0,5 %

PHARMACEUTICALS IRELAND not available

BE153273

Augentropfen, Lösung ACULARE 0,5 % collyre

ALLERGAN

BE

PHARMACEUTICALS IRELAND not available

en solution

List of nationally authorised medicinal products EMA/154207/2018

BE153273

ALLERGAN

BE

PHARMACEUTICALS IRELAND

Page 3/4

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

ACULARE 0,5 % collyre

not available

2007019157

ALLERGAN

LU

en solution ACULARE 0,5%

PHARMACEUTICALS IRELAND not available

BE153273

oogdruppels, oplossing Ketorolac trometamol

ALLERGAN

BE

PHARMACEUTICALS IRELAND UK/H/4540/001

PL 25298/0068

BROWN & BURK UK LIMITED

UK

AT/H/0518/001/DC

1-30636

OMNIVISION GMBH

AT

AT/H/0518/001/DC

79179.00.00

OMNIVISION GMBH

DE

0.5% w/v eye drops, solution KetoVision 5 mg/ml Augentropfen, Lösung KetoVision 5 mg/ml Augentropfen, Lösung

List of nationally authorised medicinal products EMA/154207/2018

Page 4/4

ketorolac (ophtalmic formulations) - European Medicines Agency

Mar 8, 2018 - National Authorisation Number. MAH of product in the member state. Member State where product is authorised. ACULAR 0,5 POUR CENT, collyre not available. NL 16248. ALLERGAN FRANCE. FR. ACULAR 0,5%. Augentropfen. IE/H/0101/001. 1-21783. ALLERGAN. PHARMACEUTICALS IRELAND. AT.

88KB Sizes 0 Downloads 164 Views

Recommend Documents

Isotretinoin (oral formulations) - European Medicines Agency - Europa ...
Jul 19, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our ... List of nationally authorised medicinal products.

triamcinolone (intraocular formulations) - European Medicines Agency
Oct 26, 2017 - Authorisation number. National Authorisation Number. MAH of product in the member state. Member State where product is authorised. TRIESENCE 40 mg/ml, sospensione iniettabile. DE/H/2294/001. 042015014. ALCON ITALIA S.P.A.. IT. Triesenc

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Finasteride - European Medicines Agency - europa.eu
Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Implant used to help new bone develop in patients with spinal disc problems and leg fractures .... E-mail [email protected] Website www.ema.europa.eu.

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Committee_Meeting dates_2017 - European Medicines Agency
Sep 26, 2016 - An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

dexlansoprazole, lansoprazole - European Medicines Agency
European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. 13 September 2017. EMA/727763/2017. Human Medicines Evaluation Division. List of nationally authorised medicinal products. Active substance(s): dexlansop

monthly figures - December 2016 - European Medicines Agency
Jan 10, 2017 - Applicants can request a re-examination. The first four rows present the outcome of the evaluation before a re-examination (or a.